EP Patent

EP1007119B1 — Breath coordinated inhaler

Assigned to Kos Life Sciences Inc · Expires 2003-12-10 · 22y expired

What this patent protects

An improved breath coordinated inhaler (10) is provided for administering medication to a patient in aerosol form for respiratory inhalation therapy. The improved inhaler (10) comprises a compact housing (18) adapted to receive and support a medication canister (12), including a …

USPTO Abstract

An improved breath coordinated inhaler (10) is provided for administering medication to a patient in aerosol form for respiratory inhalation therapy. The improved inhaler (10) comprises a compact housing (18) adapted to receive and support a medication canister (12), including a valve assembly (14) actuated to deliver a dosage of the medication in aerosol form. The housing (18) includes a plunger mounted at a first end thereof for displacing the canister against a spray nozzle (24) located at a second end of the housing to actuate the valve assembly (14), and deliver the medication through a mouthpiece (26) to the patient. The plunger (36) is associated with a seal arrangement for venting the housing (18) when the plunger is depressed to allow the patient to draw in air in timed relation to the medication delivery, and to substantially reseal the housing (18) against ingress of contaminants when the plunger (36) is released.

Drugs covered by this patent

Patent Metadata

Patent number
EP1007119B1
Jurisdiction
EP
Classification
Expires
2003-12-10
Drug substance claim
No
Drug product claim
No
Assignee
Kos Life Sciences Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.